DynamiCure Biotechnology
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
830 Winter St Ste 1, Waltham, Massachuse...Phone Number
(781) 373-9136Website
www.dynamicure.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
2
1
1
About DynamiCure Biotechnology
DynamiCure is focused on innovative drug discovery, specifically through immuno-normalization insights, to develop therapeutic antibody candidates with the potential to be first-in-class and best-in-class. The company aims to revolutionize the treatment of various cancers, autoimmune diseases, and potentially other conditions. Their dedicated team is committed to advancing next-generation medicines for patients worldwide. DynamiCure seeks to attract individuals who are passionate about contributing to this transformative work.Explore more
DynamiCure Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DynamiCure Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
DynamiCure Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Check if DynamiCure Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when DynamiCure Biotechnology launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if DynamiCure Biotechnology had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once DynamiCure Biotechnology has new funding data
Check out if DynamiCure Biotechnology is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at DynamiCure Biotechnology
Earning: See what the market has to say on DynamiCure Biotechnology recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined DynamiCure Biotechnology as Masked Content
Find more new buyers
Compare Similar Companies to DynamiCure Biotechnology
Compare insights from companies similar to DynamiCure Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
DynamiCure Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
DynamiCure Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about DynamiCure Biotechnology.
DynamiCure Biotechnology Tech Stack
A closer look at the technologies used by DynamiCure Biotechnology
See more technologies
Most Recent Scoops
Left Company
Executive Move
Open Position
Open Position
New Hire
Executive Move
DynamiCure Biotechnology News & Media
ImaginAb Executes License and Supply Agreement for CD8 ImmunoPET Technology with DynamiCure Biotechnology
LOS ANGELES, Nov. 15, 2022 /PRNewswire/ -- ImaginAb Inc., a global biotechnology company focused on developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPETâ„¢) imaging agent and radiopharmaceutical therapy (RPT) products, today announced the signing of a new multi-year, non-exclusive license...DynamiCure Announces Appointment of Industry Veteran Peter Lasky as its First Chief People Officer
Appointment strengthens senior leadership team as company advances its first candidate into the clinic and prepares to expand its pipeline with a focus on immuno-normalization Appointment strengthens senior leadership team as company advances its first candidate into the clinic and prepares to expand its pipeline with a focus on immuno-normalizationDynamiCure Announces IND Clearance to Advance First Antibody Candidate from its DC-6001 Anti-CD93 Program into Clinical Development
DCBY02 to be assessed in patients with advanced or metastatic solid tumors across dose-escalation and dose-expansion parts of a Phase 1 clinical study DCBY02 to be assessed in patients with advanced or metastatic solid tumors across dose-escalation and dose-expansion parts of a Phase 1 clinical study
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding DynamiCure Biotechnology
Sign Up For FreeTo access detailed company insights
DynamiCure is focused on innovative drug discovery, specifically through immuno-normalization insights, to develop therapeutic antibody candidates with the potential to be first-in-class and best-in-class. The company aims to revolutionize the treatment of various cancers, autoimmune diseases, and potentially other conditions. Their dedicated team... Read More
